Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2006-03-09 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAN NICOLAO (20230), None
SELURL PHARMACIE SIMONI : revenue, balance sheet and financial ratios
SELURL PHARMACIE SIMONI is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAN NICOLAO (20230),
this company of category PME
shows in 2021 a revenue of 3.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELURL PHARMACIE SIMONI (SIREN 488994112)
Indicator
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
3 030 107 €
2 663 406 €
2 807 895 €
2 863 785 €
2 722 715 €
2 681 018 €
Net income
221 317 €
242 916 €
173 344 €
218 717 €
244 603 €
281 088 €
247 867 €
EBITDA
N/C
318 284 €
255 787 €
307 673 €
350 507 €
420 311 €
385 311 €
Net margin
N/C
8.0%
6.5%
7.8%
8.5%
10.3%
9.2%
Revenue and income statement
In 2022, SELURL PHARMACIE SIMONI generates positive net income of 221 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2022: 248 k€ -> 221 k€.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
221 317 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 220%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 28%. The balance between equity and debt is satisfactory.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
219.885%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
27.584%
Asset age ratio (2022)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
Debt ratio
11.207
1.665
0.286
1.406
1.374
2.352
219.885
Financial autonomy
78.946
86.971
88.646
88.576
86.801
85.741
27.584
Repayment capacity
0.815
0.122
0.025
0.145
0.173
0.248
None
Cash flow / Revenue
9.489%
10.765%
9.024%
7.902%
6.997%
7.716%
None%
Sector positioning
Debt ratio
219.882022
2020
2021
2022
Q1: 24.52
Med: 74.72
Q3: 182.51
Average+50 pts over 3 years
In 2022, the debt ratio of SELURL PHARMACIE SIMONI (219.88) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
27.58%2022
2020
2021
2022
Q1: 28.54%
Med: 47.06%
Q3: 66.61%
Average-53 pts over 3 years
In 2022, the financial autonomy of SELURL PHARMACIE SIMONI (27.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
0.25 years2021
2020
2021
Q1: 1.06 years
Med: 3.56 years
Q3: 7.31 years
Excellent
In 2021, the repayment capacity of SELURL PHARMACIE SIMONI (0.25) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 222.81. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
Liquidity ratio
150.026
195.228
224.004
271.714
261.154
294.723
222.807
Interest coverage
2.348
0.879
0.563
0.039
0.081
0.0
None
Sector positioning
Liquidity ratio
222.812022
2020
2021
2022
Q1: 145.17
Med: 199.48
Q3: 274.99
Good-17 pts over 3 years
In 2022, the liquidity ratio of SELURL PHARMACIE SIMONI (222.81) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.0x2021
2020
2021
Q1: 0.27x
Med: 2.43x
Q3: 5.92x
Average
In 2021, the interest coverage of SELURL PHARMACIE SIMONI (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2022)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2022)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2022)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2022)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELURL PHARMACIE SIMONI
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
Operating WCR
170 888 €
187 758 €
210 316 €
206 886 €
150 935 €
88 873 €
0 €
Inventory turnover (days)
19
18
18
21
20
16
0
Customer payment term (days)
6
8
5
6
7
8
0
Supplier payment term (days)
46
44
41
38
42
36
0
Positioning of SELURL PHARMACIE SIMONI in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of SELURL PHARMACIE SIMONI is estimated at
2 604 128 €
(range 1 750 491€ - 3 905 708€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
1750k€2604k€3905k€
2 604 128 €Range: 1 750 491€ - 3 905 708€
NAF 5 année 2022
Valuation method used
Net Income Multiple
221 317 €
×
11.8x
=2 604 128 €
Range: 1 750 492€ - 3 905 709€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELURL PHARMACIE SIMONI with other companies in the same sector:
Frequently asked questions about SELURL PHARMACIE SIMONI
What is the revenue of SELURL PHARMACIE SIMONI ?
The revenue of SELURL PHARMACIE SIMONI in 2021 is 3.0 M€.
Is SELURL PHARMACIE SIMONI profitable?
Yes, SELURL PHARMACIE SIMONI generated a net profit of 221 k€ in 2022.
Where is the headquarters of SELURL PHARMACIE SIMONI ?
The headquarters of SELURL PHARMACIE SIMONI is located in SAN NICOLAO (20230).
Where to find the tax return of SELURL PHARMACIE SIMONI ?
The tax return of SELURL PHARMACIE SIMONI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELURL PHARMACIE SIMONI operate?
SELURL PHARMACIE SIMONI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart